Published in Postgrad Med J on November 01, 1975
Indices of potential lead hazard. Environ Health Perspect (1977) 0.80
Blood-lead levels, behaviour, and intelligence. A population study. Lancet (1974) 2.75
Lead and hyperactivity. Lancet (1972) 2.42
Environmental lead pollution in an urban soft-water area. Br Med J (1972) 2.28
The diagnosis of industrial lead poisoning. Br J Ind Med (1968) 2.23
Lead poisoning in rural Scotland. Br Med J (1972) 2.08
THE RELATIONSHIP OF LEAD POISONING TO ACUTE INTERMITTENT PORPHYRIA. Q J Med (1965) 1.71
Lead absorption from the intestine in newborn rats. Nature (1971) 1.47
Role of chronic low-level lead exposure in the aetiology of mental retardation. Lancet (1975) 1.39
Hyperactivity and brain catecholamines in lead-exposed developing rats. Science (1973) 1.26
Renal ultrastructure, renal function, and parameters of lead toxicity in workers with different periods of lead exposure. Br J Ind Med (1974) 1.25
Tetraethyl-lead poisoning. Lancet (1972) 1.18
Decreased antibody formation in mice exposed to lead. Nature (1974) 1.11
The uptake of lead by children in differing environments. Environ Health Perspect (1974) 1.10
Acute lead poisoning: Five cases resulting from self-injection of lead and opium. Q J Med (1975) 0.98
Na plus-K plus-ATPase activity of erythrocyte membranes: in urban populations not occupationally exposed to lead. Arch Environ Health (1973) 0.94
Changes in obsessive/compulsive patients as measured by the Leyton Inventory before and after treatment with clomipramine. Scott Med J (1975) 0.84
Development of behavioral tests for the assessment of neurologic effects of lead in sheep. Environ Health Perspect (1974) 0.83
A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br (2003) 4.16
Blood-lead and hypertension. Lancet (1976) 2.82
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant (2012) 2.46
Environmental lead pollution in an urban soft-water area. Br Med J (1972) 2.28
The diagnosis of industrial lead poisoning. Br J Ind Med (1968) 2.23
Do pregnant women take their iron? Lancet (1969) 2.10
Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A (1997) 2.08
Lead poisoning in rural Scotland. Br Med J (1972) 2.08
Summaries and selective destruction as a solution to the hospital record storage problem. Lancet (1967) 2.05
Choleic acids. Biochem J (1932) 2.02
Lead and delta-aminolaevulinic acid dehydratase levels in mentally retarded children and in lead-poisoned suckling rats. Lancet (1970) 1.93
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
Body mass index and the risk of obesity in coeliac disease treated with the gluten-free diet. Aliment Pharmacol Ther (2012) 1.89
Diagnosis of upper gastro-intestinal bleeding. Br Med J (1965) 1.84
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant (2013) 1.77
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
Skin test results and self-reported symptom severity in allergic rhinitis: The role of psychological factors. Clin Exp Allergy (2006) 1.59
The drug disc. Warning system for drug interactions. Lancet (1973) 1.56
An assessment of digoxin radio-immunoassay. Scott Med J (1973) 1.55
Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends Biochem Sci (1998) 1.55
Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy (1999) 1.52
Magnesium binding by Escherichia coli ribosomes. J Mol Biol (1966) 1.46
Depression of delta-aminolaevulic acid dehydrase activity by ethanol in man and rat. Clin Sci (1971) 1.45
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology (1996) 1.45
Blood lead levels in normal and mentally deficiency children. Arch Dis Child (1967) 1.41
Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension. Am J Cardiol (2001) 1.41
Ascorbic-acid levels in leucocytes of patients with gastrointestinal haemorrhage. Lancet (1968) 1.40
Writing case histories. Int J Psychoanal (1997) 1.39
Medics in the Israel Defense Forces and their experience in trauma care during peacetime. Isr Med Assoc J (1999) 1.38
Between empathy and judgment. J Am Psychoanal Assoc (1999) 1.38
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Acute intermittent porphyria: response of tachycardia and hypertension to propranolol. Br Med J (1973) 1.35
Treatment with haematin in acute hepatic porphyria. Q J Med (1981) 1.29
Renal insufficiency associated with excessive lead exposure. Br Med J (1977) 1.29
Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-yr-old men. J Appl Physiol (1985) (1994) 1.29
Lead poisoning as a disorder of heme synthesis. Semin Hematol (1968) 1.22
Drinking water as a source of lead pollution. Environ Health Perspect (1974) 1.19
Induction of delta-aminolaevulinic acid synthase in leucocytes of patients on phenytoin therapy--comparison with changes in rat hepatic tissue. Br J Clin Pharmacol (1980) 1.19
Tetraethyl-lead poisoning. Lancet (1972) 1.18
Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities. J Med Genet (1982) 1.15
[Contribution of lead in drinking water to blood-lead]. Lancet (1977) 1.15
Measurement of leucocyte ascorbic acid. Br Med J (1966) 1.12
Lead poisoning and haem biosynthesis. Br J Haematol (1972) 1.11
Hereditary coproporphyria. Lancet (1967) 1.11
Blood-lead and cadmium in human hypertension. J Environ Pathol Toxicol (1980) 1.09
Autonomic neuropathy in acute intermittent porphyria. J Neurol Neurosurg Psychiatry (1985) 1.07
mu-opioid receptors are present in vagal afferents and their dendritic targets in the medial nucleus tractus solitarius. J Comp Neurol (2000) 1.05
Refractory anemia with dysproteinemia: long-term therapy with low-dose corticosteroids. Blood (1973) 1.05
Rapid degradation of an abnormal protein in Escherichia coli proceeds through repeated cycles of association with GroEL. J Biol Chem (1999) 1.05
The effect of calcium on lead absorption in rats. Biochem J (1977) 1.05
Radiochromium in the selection of patients with haemolytic anaemia for splenectomy. Lancet (1966) 1.04
Maternal lead levels after alterations to water supply. Lancet (1981) 1.03
Effects of aluminium, lead and zinc on delta-aminolaevulinic acid dehydratase. Enzyme (1977) 1.03
Acute hepatic porphyrias. Clin Haematol (1980) 1.02
Detection of latent pernicious anaemia in iron-deficiency anaemia. Br Med J (1966) 1.02
Enzyme abnormalities in the porphyrias. Lancet (1977) 1.02
Experimental griseofulvin porphyria in adult and foetal mice. Br J Dermatol (1967) 1.01
Incidence of iron deficiency, with and without anaemia, in women in general practice. Br J Haematol (1967) 1.01
A retrospective analysis of blood-lead in mentally retarded children. Lancet (1977) 1.00
The effect of lead and ferrous and ferric iron on delta-aminolaevulic acid synthetase. Clin Sci (1969) 1.00
Blood-cadmium in hypertensives and normotensives. Lancet (1976) 1.00
The accuracy of diagnostic laparoscopy in trauma patients: a prospective, controlled study. Int Surg (1999) 0.99
Is porphobilinogen deaminase activity a secondary control mechanism in haem biosynthesis in humans? [proceedings]. Biochem Soc Trans (1977) 0.99
Excessive urinary excretion of certain porphyrinogenic steroids in human acute intermittent porphyria. Lancet (1969) 0.98
The relationship between receptor-effector unit heterogeneity and the shape of the concentration-effect profile: pharmacodynamic implications. J Pharmacokinet Biopharm (1994) 0.97
The human frequency-following response: its behavior during continuous tone and tone burst stimulation. Electroencephalogr Clin Neurophysiol (1976) 0.97
Combined surgery and postoperative radiotherapy for carcinoma of the base of radiotherapy for carcinoma of the base of tongue: analysis of treatment outcome and prognostic value of margin status. Head Neck (1997) 0.96
Comparison of high-calorie, low-nutrient-dense food consumption among obese and non-obese adolescents. Obes Res (1999) 0.96
mu-Opioid receptors often colocalize with the substance P receptor (NK1) in the trigeminal dorsal horn. J Neurosci (2000) 0.96
Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope (2001) 0.96
A protocol for uvulopalatopharyngoplasty, mortised genioplasty, and maxillomandibular advancement in patients with obstructive sleep apnea: an analysis of 40 cases. J Oral Maxillofac Surg (2001) 0.96
Cytochrome oxidase in latent iron deficiency (sideropenia). Br J Haematol (1966) 0.95
A new immunologic test for CNS cysticercosis. Neurology (1984) 0.95
Hepatic delta-aminolaevulinic acid synthetase in an attack of hereditary coproporphyria and during remission. Lancet (1971) 0.95
-Aminolevulinic acid dehydrase activity in the blood of men working with lead alkyls. Br J Ind Med (1972) 0.94
The contribution of drinking water lead to maternal blood lead concentrations. Clin Chim Acta (1979) 0.94
Trisomies 9 and 8 detected by fluorescence in situ hybridization in patients with systemic mastocytosis. J Allergy Clin Immunol (1996) 0.94
Value of erythrocyte protoporphyrin in the diagnosis of latent iron deficiency (sideropenia). Br J Haematol (1966) 0.93
13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): validation and acute toxicity testing. Environ Health Perspect (1998) 0.93
Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension. Clin Ther (2001) 0.93
Nonradiologist utilization of American College of Radiology Appropriateness Criteria in a preauthorization center for MRI requests: applicability and effects. AJR Am J Roentgenol (2006) 0.93
Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. J Pharmacol Exp Ther (1999) 0.92
Magnetic resonance imaging in acute spinal cord trauma. Neurosurgery (1988) 0.92
Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur J Clin Invest (1980) 0.92
Refractory anaemia with dysproteinaemia: response to small doses of steroid. Br J Haematol (1968) 0.92
Alterations in haem biosynthesis during the human menstrual cycle: studies in normal subjects and patients with latent and active acute intermittent porphyria. Clin Sci (Lond) (1982) 0.92
The biosynthesis of haem in congenital (erythropoietic) porphyria. Int J Biochem (1978) 0.91
Proceedings: Central uptake and cardiovascular effects of delta-aminolaevulinic acid. Br J Pharmacol (1973) 0.91
Some studies of maternal and infant lead exposure in Glasgow. Scott Med J (1982) 0.91
Pregnancy and the acute porphyrias. Br J Obstet Gynaecol (1977) 0.90
Mass casualty incident management, triage, injury distribution of casualties and rate of arrival of casualties at the hospitals: lessons from a suicide bomber attack in downtown Tel Aviv. Emerg Med J (2008) 0.90
The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation. Eur J Clin Pharmacol (1977) 0.90
17-Oxosteroid conjugates in plasma and urine of patients with acute intermittent porphyria. Clin Sci Mol Med (1974) 0.90
The outcome of total ankle replacement: a systematic review and meta-analysis. Bone Joint J (2013) 0.90
Lead effects on the heme biosynthetic pathway. Relationship to toxicity. Ann N Y Acad Sci (1987) 0.90
Immunologic measurement of elastin-derived peptides in human serum. Am Rev Respir Dis (1983) 0.90
Diploma in pharmaceutical medicine. Br J Clin Pharmacol (1981) 0.90
Wallstent placement in a renal artery after blunt abdominal trauma. J Trauma (1999) 0.90
Pathogenesis and treatment of acute intermittent porphyria: discussion paper. J R Soc Med (1983) 0.90
Early-onset chronic renal failure as a complication of acute intermittent porphyria. Q J Med (1983) 0.90